As of January 23, 2025, Monsenso A/S (MONSO.CO) has a market cap of $3.403 million USD. According to our data, Monsenso A/S is ranked No.9124 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $3.40 M |
-0.54%
|
Dec 30, 2024 | $3.42 M |
27.34%
|
Dec 29, 2023 | $2.69 M |
-34.32%
|
Dec 30, 2022 | $4.09 M |
-63.27%
|
Dec 30, 2021 | $11.14 M |
-89.00%
|
Dec 30, 2020 | $0.10 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Teladoc Health
TDOC
|
$1.70 B |
-0.000 M
|
USA
|
Allscripts
MDRX
|
$0.92 B |
0.000 M
|
USA
|
Health Catalyst
HCAT
|
$0.34 B |
0.000 M
|
USA
|
Veeva Systems
VEEV
|
$37.19 B |
0.002 M
|
USA
|
Omnicell
OMCL
|
$1.97 B |
0.000 M
|
USA
|
Phreesia
PHR
|
$1.58 B |
0.000 M
|
USA
|
Evolent Health
EVH
|
$1.15 B |
-0.000 M
|
USA
|
Cerus
CERS
|
$0.34 B |
0.000 M
|
USA
|
Market Cap | = | MONSO.CO Stock Price | * | MONSO.CO Shares Outstanding |
= | $0.05 | * | 66.64 M | |
= | $3.40 M |